Demethyleneberberine

Demethyleneberberine is a natural drug that inhibits the Cox-2 enzyme, which is involved in the production of prostaglandins. It also inhibits the activity of various receptors and has been shown to decrease the level of dextran sulfate in blood plasma. Demethyleneberberine has been shown to have hypoglycemic effects by improving insulin sensitivity and increasing glucose uptake. This drug has been found to be useful for treating bowel disease, as well as metabolic disorders such as congestive heart failure. Demethyleneberberine is a pro-apoptotic protein that binds to polycyclic aromatic hydrocarbons and coumarin derivatives through its polyphenolic group, which are metabolized by oxidative reactions or reductive reactions. These reactions can be analyzed using liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) methods.